Please provide your email address to receive an email when new articles are posted on . A new expert consensus decision pathway published by the American College of Cardiology highlights the ...
OXFORD, England, Jan. 10, 2024 /PRNewswire/ -- Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with ...
New criteria could lead to a diagnosis on the basis of a simple blood test, even in the absence of obvious symptoms. By Paula Span Determining whether someone has Alzheimer’s disease usually requires ...
Prof. Liu Cong from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, ...
Please provide your email address to receive an email when new articles are posted on . C 2 N Diagnostics released the PrecivityAD2 blood test, which uses positron emission tomography scans and ...
Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback